YMC

PeptiStar Inc., founded in 2017 and headquartered in Osaka, Japan, specializes in the development and manufacturing of peptide medicines. As a Contract Development and Manufacturing Organization (CDMO), PeptiStar offers a range of services for peptide active pharmaceutical ingredients (APIs), including traditional and advanced forms such as macrocyclic and stapled peptides that incorporate non-natural amino acids. The company focuses on innovative manufacturing technologies to enhance the efficiency and effectiveness of peptide therapeutics, thereby supporting the pharmaceutical industry in accelerating drug development. Through its commitment to open innovation, PeptiStar aims to deliver high value-added services to its clients, contributing significantly to advancements in peptide medicine.

ChromaCon AG is a biopharmaceutical tool company based in Zurich, Switzerland, specializing in chromatographic process technologies for the life sciences sector. Founded in 2006, the company provides a range of equipment and services aimed at enhancing separation, purification, and analysis processes. Its primary offerings include the Contichrom platform, which supports various chromatographic methods such as batch, affinity, and multicolumn countercurrent solvent gradient purification. ChromaCon's systems, including the Contichrom Lab-10 and Prep-100, are designed for both discovery and scale-up applications, facilitating the purification of biotechnological products, food ingredients, and chemical intermediates. The company also offers feasibility studies, process development, and operator training services. ChromaCon's equipment is operated using its proprietary ChromIQ software, which allows for versatile operation across different chromatographic processes. In addition to its innovative technology, ChromaCon has established a strategic partnership with JSR Corporation and markets its products through global partners while operating as a subsidiary of YMC CO., LTD.